Sign in
4

Changes in Ownership

Odyssey Health, Inc. Filed Acc 0001683168-22-008022

Options or other derivatives

  • Chief Commercial Officer acquired 600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Emerson Erik C. Chief Commercial Officer 2022-11-01 Grant or award · Stock Option - Right to buy +125,000 $0.25 $31,250 125,000 D: show line 1 in the form
Emerson Erik C. Chief Commercial Officer 2022-11-01 Grant or award · Stock Option - Right to buy +475,000 $0.25 $118,750 0 D: show line 2 in the form
Loading xslF345X03/ownership.xml…